For many years, the drug Zantac (ranitidine), manufactured by the pharmaceutical company Sanofi and in generic form by other companies, was used by people all across the U.S. in both prescription and over-the-counter formulation to treat various acid-related gastrointestinal issues. Recent studies have shown that ranitidine can interact inside the human body to form a chemical compound known to potentially cause cancer.
Users of Zantac and ranitidine have come forward over the past several months to allege that their cancers were caused by their use of Zantac/ranitidine. They contend that Sanofi and other generic manufacturers knew about the heightened risks of cancer caused by use of the drug and failed to disclose this information to physicians and to the public.
Increasing evidence of the dangers of use of Zantac/ranitidine have led retailers to stop selling the drug and caused the FDA to request manufacturers withdraw it from the U.S. market.
If you have previously taken Zantac or ranitidine and have been diagnosed with cancer or another medical condition, you may be entitled to financial compensation for your medical treatments, lost income, and pain and suffering if it can be shown that your condition is linked to your use of Zantac/ranitidine.
Don’t wait another day to begin the process of pursuing the compensation you and your family need and deserve. Contact Ward Black Law today for a free initial case review to discuss your rights and options and to learn more about how a Zantac law firm can help you achieve the outcome you deserve in your case.
Zantac, also known by its generic formulation name of ranitidine, functions as an H2 blocker, decreasing stomach acid by blocking histamine receptors in the stomach. Zantac/ranitidine has been prescribed and used in over-the-counter formulations to treat peptic ulcers, GERD, and other gastrointestinal issues.
However, recent independent laboratory testing led to a petition filed with the FDA claiming that Zantac can cause high levels of the compound nitrosodimethylamine (NDMA) in users of the drug. The studies claim that Zantac or ranitidine is an unstable molecule that breaks down in the digestive tract and comes into contact with nitrates in the tract to form NDMA, leading to high levels of the compound in the patient’s body.
NDMA is listed as a likely carcinogenic compound for humans. The compound is used in laboratory testing to induce cancers in rats and mice. NDMA exposure has been associated to various kinds of cancers, including:
The potentially toxic nature of NDMA can also cause other damage to the liver, bladder, brain, kidneys, stomach, and lungs.
In 2019, Valisure, an online pharmacy, advised the FDA that it had found NDMA in various batches of Zantac and ranitidine produced by multiple different manufacturers. As a result of the petition, retailers across the U.S. began withdrawing prescription and over-the-counter formulas of Zantac and ranitidine from their shelves.
This ultimately led to Zantac’s manufacturer, Sanofi, and 14 manufacturers of generic ranitidine to recall the medication in the U.S. By April 2020, the FDA requested manufacturers of all ranitidine-containing products withdraw their products from the U.S., after additional testing by the agency showed the drug posed a risk to public health.
Unlike other prior medication recalls that were motivated by discoveries that batches of drugs had been contaminated by NDMA, Zantac/ranitidine was recalled because testing had confirmed that the drug had the capacity to form NDMA inside the human body.
The recall of Zantac has led to numerous lawsuits against Sanofi and manufacturers of generic ranitidine, claiming they knew of the risk that Zantac/ranitidine could form NDMA in the human body but failed to warn the public of these risks.
The first lawsuit was filed in late 2019 by a man who had been taking Zantac since 2009 and developed breast cancer, a rare condition in men, in 2013. Other cases were filed shortly thereafter, with plaintiffs claiming they had developed bladder and other gastrointestinal cancers.
These Zantac/ranitidine lawsuits were consolidated by the U.S. Judicial Panel on Multidistrict Litigation in February 2020 into the Southern District of Florida. Over 140 cases are currently pending in the MDL.
Users of Zantac or ranitidine who have developed cancers or other medical conditions linked to exposure to NDMA may be entitled to file a claim for compensation for the physical injuries, harm, and other damages they have incurred.
In addition, several class-action lawsuits have been filed on behalf of users of Zantac/ranitidine, including those who have not yet been diagnosed with cancer or suffered any other serious adverse side effects, seeking refunds of their purchase price due to the defective nature of the drug and manufacturers’ failure to disclose this defect to purchasers.
A person who has developed cancer after taking high doses of Zantac/ranitidine for at least one year or who has taken any dosage of the drug over an extended period of time may be entitled to seek compensation for damages including:
If you have a close family member who has passed away due to cancer that may have been caused by Zantac/ranitidine use, you and your family may also be entitled to wrongful death damages. These may include the loss of your loved one’s services and financial contributions to your family and household and for the loss of your loved one’s companionship, society, guidance, care, and advice.
If you’ve been diagnosed with cancer or otherwise harmed due to use of Zantac or ranitidine, you have a limited period under North Carolina’s statute of limitations to file a lawsuit to seek compensation for your damages.
In North Carolina, you generally have three years from the date you are diagnosed with a medical condition or otherwise learn that you have been harmed by Zantac/ranitidine use to file your lawsuit.
If you fail to file your lawsuit prior to the expiration of the limitations period, the court can permanently dismiss your lawsuit and you will lose your right to seek compensation in court.
In North Carolina, if your loved one has died, a wrongful death claim must generally be filed within two years of the date of death. We can help you understand these time limits in your particular case.
If you are suffering from cancer and suspect that it was caused by your use of Zantac or ranitidine, you may be wondering “how can a Zantac lawsuit attorney near me help?” When you choose Ward Black Law to represent you in your claim against the drug manufacturers for compensation for the harm you have suffered, you can expect that our skilled, dedicated legal team will:
Known side effects of Zantac or ranitidine include:
If these side effects become severe or don’t go away on their own after a few days, you should talk to your prescribing physician.
Other serious side effects of Zantac/ranitidine use may include:
If you experience any of these serious side effects, you should call your doctor. If you believe these side effects or symptoms may be life-threatening or if you feel you are experiencing a medical emergency, call 911 or go to the emergency room.
If you have been diagnosed with cancer or another medical condition and you are taking Zantac or ranitidine or have taken the drug in the past, you should consider the following steps. They may help you protect your legal rights and your options for seeking compensation for the harm you have suffered due to Zantac/ranitidine. They may also help document your damages and help establish the amount of compensation you may be entitled to:
If you have been diagnosed with cancer and you have a history of using Zantac or the generic version ranitidine, you may be entitled to financial compensation. Contact us for a free, no-obligation case evaluation. Ward Black Law’s Zantac lawsuit attorneys can help you understand your rights and how we can help confidentially and at no charge.